“CHALLENGING ISSUES IN INFECTIVE ENDOCARDITIS”. ISKANDER AL-GITHMI, MD, FRCSC Consultant Cardiothoracic Surgeon Assistant Professor of Surgery King Abdulaziz University. CHALLENGING ISSUES IN INFECTIVE ENDOCARDITIS. “Endocarditis Milestones”. .
ISKANDER AL-GITHMI, MD, FRCSC
Consultant Cardiothoracic SurgeonAssistant Professor of Surgery
King Abdulaziz University
Clinical syndrome; described by Sir William Osler.
It is of use, from time to time, to take stock, so to speak of our knowledge of a particular disease, to see exactly where we stand in regards to it, to inquire to what conclusion the accumulated facts seem to point and to ascertain in what direction we may look for fruitful investigation in the future….I propose to do this in the case of that most interesting disease known as ulcerative endocarditis.
Penicillin (Alexander Fleming)
Von Reyn Criteria [Persistant bacteremia, New regurgitant murmur and vascular Complications]
Duke’s Criteria proposed by Dr. Durack from Duke University.
Despite improvement in health care and advancement in diagnostic technology and therapy; the incidence of infective endocarditis has not decreased over the past decades.
Progressive evolution in risk factors:
i.e. i.v. drug use
Use of prosthetic valve
Growing resistant micro-organisms.
Incidence of Infective endocarditis ~ 15000 to 20,000 new cases per year.
Infective endocarditis classifications:
Native – valve endocarditis: associated with congenital heart disease and chronic rheumatic heart disease.
1-5% of individual with infective endocarditis have PVE
Early-PVE: infection within 60 days of surgery
Late -PVE: infection 2-6 months of surgery
Infective endocarditis in intravenous drug user
Common in young population
Tricuspid valve involved in up to 50% of cases
Predominant pathogenes usually staph aureus
Important iatrogenic risk factors for infective endocarditis - hemodialysis
3 times more frequent than in general population
Predominant pathogenes is staph aureus.
Bacterial adherence to damaged valve:
High index of suspicious
Early TEE: High sensitivity 75-95%
Duke Clinical Criteria
It is multi-disciplinary and team work
“Echocardiography in infective endocarditis”
Extremely important not only to make diagnosis but for early detection of potential complications.
Peri-annular extension of infection and annular dehiscence
Major 30 – 40%
Up to 65% of embolic event involve CNS
90% of CNS embolism lodge in the distribution of middle cerebral artery.
More than 90% of embolization developed within the 1st 3 weeks of the diagnosis of infective endocarditis
The rate of embolization decreased overtime during anti-microbial therapy.
Results of Previous Studies
Echocardiography predicts embolic events in infective endocarditis.
Study design: Prospective
Patients: 178 Consecutive patients with definite diagnosis of infective endocarditis
All had multi-plane TEE
Results of Univariate and Multiple Stepwise Logistic Regression Analyses
“Clinical Implications of the Study”
The presence of vegetation visualized by echocardiogram is a predictive of embolism
The morphological characteristic of vegetations are very helpful in predicting the embolic events.
“What is the time interval required for surgical intervention in infective endocarditis?”
Presence of vegetations is a strong indication for surgical intervention, irrespective of valve destruction, heart failure or response to anti-microbial therapy.
Embolic events is extremely high in the early stage of the disease.
Embolic events can occur up to 20% of cases from vegetation less than 10mm.
“Congestive Heart Failure (CHF)”
CHF may develop insidiously, despite appropriate antibiotics as a result of progressive valvular insufficiency and ventricular dysfunction.
CHF in infective endocarditis; portends a grave prognosis with medical therapy.
Delaying surgery to the point of ventricular decompensation dramatically increase operative mortality from 6% to 11% for patient without CHF, 17-33% for patient with CHF.
Extension of infective endocarditis beyond the valve annulus predict higher mortality, more frequent development of CHF and the need for surgical intervention.
It occurs in 10-40% of all native-valve endocarditis and 56% to 100% in PVE.
CHALLENGING ISSUES IN INFECTIVE ENDOCARDITIS
“Management Approach to Infective Endocarditis”
Surgical versus medical therapy in active complicated native valve infective endocarditis.
Indications for Surgery (Group A) and Criteria for Inclusion in Group B
Site of Involvement by Endocarditis
Despite improvement in healthcare and major advance in the diagnostic technology as well as medical-surgical therapies, endocarditis has not decreased but new risk factors have evolved.
Treatment of this infection require a multidisciplinary approach.
Early surgery is critically important and maybe the only best option in patients with infective endocarditis irrespective of heart failure, valve destruction and response to antimicrobial therapy.
New clinical research studies should be used to provide definite answers to several remaining questions about this complex infection.
CHALLENGING ISSUES IN INFECTIVE ENDOCARDITIS